
Otxone 250mg Injection
Marketer
Yew Biotech
Salt Composition
Ceftriaxone (250mg)
Overview Otxone 250mg Injection
Cephalosporin antibiotic Otxone 250mg Injection combats various bacterial infections. Its applications span a wide range, including infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactically, it can also prevent surgical site infections. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional, dosage is determined individually. Consistent, evenly spaced doses are crucial; completing the prescribed course is vital, even with symptom improvement, to prevent relapse. Common side effects—diarrhea, rash, altered liver function tests, and variations in blood cell counts (e.g., elevated eosinophils, reduced white blood cells, low platelets)—are generally mild, but should be reported. Pre-treatment disclosure of antibiotic allergies, kidney, or liver issues is essential, along with a complete list of current medications due to potential interactions.
Primary Ingredients of Otxone 250mg Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Otxone 250mg Injection
Managing bacterial diseases
Major Benefits of Otxone 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Otxone 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Otxone 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Otxone 250mg Injection works:
Otxone 250mg Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
Otxone 250mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Otxone 250mg Injection is considered safe. Research largely indicates minimal or absent risk to the fetus.
Breast feedingCAUTION
Administering Otxone 250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Otxone 250mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Otxone 250mg Injection can be used safely by individuals with kidney conditions; no dosage modification is necessary. Nevertheless, disclosure of any pre-existing kidney disease to your physician is advisable.
LiverCAUTION
For individuals with severe hepatic impairment, Otxone 250mg Injection requires careful administration and potential dosage modification. Patients with mild to moderate liver disease, however, do not typically require altered Otxone 250mg Injection dosages. Physician consultation is advised.
What if you forget to take Otxone 250mg Injection :
Omit doses of Otxone 250mg Injection only after contacting your physician.
Facts to Know About Otxone 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
